The Non-Homologous End Joining Protein PAXX Acts to Restrict HSV-1 Infection
AbstractHerpes simplex virus 1 (HSV-1) has extensive interactions with the host DNA damage response (DDR) machinery that can be either detrimental or beneficial to the virus. Proteins in the homologous recombination pathway are known to be required for efficient replication of the viral genome, while different members of the classical non-homologous end-joining (c-NHEJ) pathway have opposing effects on HSV-1 infection. Here, we have investigated the role of the recently-discovered c-NHEJ component, PAXX (Paralogue of XRCC4 and XLF), which we found to be excluded from the nucleus during HSV-1 infection. We have established that cells lacking PAXX have an intact innate immune response to HSV-1 but show a defect in viral genome replication efficiency. Counterintuitively, PAXX−/− cells were able to produce greater numbers of infectious virions, indicating that PAXX acts to restrict HSV-1 infection in a manner that is different from other c-NHEJ factors. View Full-Text
- Supplementary File 1:
Supplementary (PDF, 387 KB)
Share & Cite This Article
Trigg, B.J.; Lauer, K.B.; Fernandes dos Santos, P.; Coleman, H.; Balmus, G.; Mansur, D.S.; Ferguson, B.J. The Non-Homologous End Joining Protein PAXX Acts to Restrict HSV-1 Infection. Viruses 2017, 9, 342.
Trigg BJ, Lauer KB, Fernandes dos Santos P, Coleman H, Balmus G, Mansur DS, Ferguson BJ. The Non-Homologous End Joining Protein PAXX Acts to Restrict HSV-1 Infection. Viruses. 2017; 9(11):342.Chicago/Turabian Style
Trigg, Ben J.; Lauer, Katharina B.; Fernandes dos Santos, Paula; Coleman, Heather; Balmus, Gabriel; Mansur, Daniel S.; Ferguson, Brian J. 2017. "The Non-Homologous End Joining Protein PAXX Acts to Restrict HSV-1 Infection." Viruses 9, no. 11: 342.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.